Enrichment
丰富
基本信息
- 批准号:10458595
- 负责人:
- 金额:$ 12.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AwarenessBasic ScienceBiologyBloodChildClinicalCollaborationsCommunicationCommunitiesCreativenessDataDevelopmentDoctor of PhilosophyEducational workshopEnvironmentErythropoiesisExperimental HematologyFeedbackFloorFosteringFundingFutureGoalsGrantHealthHematologyHematopoiesisHigh School StudentInstitutionInterdisciplinary StudyInternationalInternetInternshipsJournalsLaboratoriesLettersMentorsMidwestern United StatesMind-Body MethodMissionMyelogenousNational Institute of Diabetes and Digestive and Kidney DiseasesNon-MalignantPediatric HospitalsPersonsPostdoctoral FellowPrincipal InvestigatorProductivityReproducibilityResearchResearch PersonnelResourcesRotationScienceScientistSecureSeriesSickle Cell AnemiaSignal TransductionTechniquesTrainingTraining ProgramsTranslational ResearchTravelVisitWorkbone marrow failure syndromecareercareer developmenteducation resourcesgraduate studentimmunohematologylecturesmeetingsmembernext generationnovelprofessorprogramsranpirnaserecruitsabbaticalstem cellssummer internshipsymposiumundergraduate studentvirtual
项目摘要
Abstract
A fundamental goal of the Cincinnati Cooperative Center of Excellence in Hematology (CCCEH) is to
facilitate scientific exchange and sharing of techniques, resources, and ideas in order to promote
creativity and productivity and foster collaborations through its Enrichment Program. The premises of
such a program are that (1) research progresses faster on the fertile ground of active discussion,
cooperation, and partnership between investigators; and (2) the main way to secure productivity in the
future is to train and nurture the next generation of researchers. The Divisions of Hematology and
Experimental Hematology at Cincinnati Children’s Hospital have a strong tradition in open exchange of
ideas and resources within the institution and with scientists from other institutions, establishing national
and international collaborations in the field of non-malignant hematology including signal transduction
in hematopoiesis and erythropoiesis, bone marrow failure syndromes, sickle cell disease, and
immunohematology. Within the previous NIDDK-P30 funded Cincinnati Center, the Principal
Investigators in these fields of science have developed a comprehensive training and mentoring
program that stimulates promising young investigators toward a research career focused on non-
malignant Hematology. Continuing on this mission, our aims within the Enrichment Core of the CCCEH
are: (1) to continue the active exchange of scientific progress and ideas between established
investigators within our center and with other centers in the ongoing weekly Hematology Grand Rounds,
and twice yearly Center Retreats to promote multidisciplinary collaborations between clinical, basic,
and translational hematology researchers; (2) to establish a Hematology Scholar training program with
the goal to foster an early-stage investigator as Scholar in non-malignant Hematology research; (3) to
sustain and enrich educational resources within our center for postdoctoral fellows and graduate
students; and (4) to support the summer training programs for undergraduate and high school students
to rotate in laboratories focusing in non-malignant hematology research, with the goal to promote
awareness and increase enthusiasm in young promising minds for research in the non-maligant
hematology field.
抽象的
辛辛那提血液学卓越合作中心(CCCEH)的基本目标是
促进科学交流并共享技术,资源和思想,以促进
通过其丰富计划,创造力,生产力和促进合作。前提
这样的程序是(1)研究在积极讨论的肥沃理由下进行得更快,
调查人员之间的合作和伙伴关系; (2)确保生产率在
未来是培训和护理下一代研究人员。血液学和
辛辛那提儿童医院的实验血液学在公开交流方面具有很强的传统
机构内的思想和资源以及其他机构的科学家,建立民族
以及在非恶性血液学领域的国际合作,包括信号转导
在造血和红细胞生成中,骨髓衰竭综合征,镰状细胞疾病和
免疫系统。在先前的NIDDK-P30资助的辛辛那提中心,校长
这些科学领域的调查人员已经开发了全面的培训和心理化
计划刺激有前途的年轻研究人员致力于专注于非 - 的研究职业
恶性血液学。继续执行此任务,我们的目标是在CCCEH的富集核心内
是:(1)继续积极地交流科学进步和既定的思想
我们中心内的调查人员以及正在进行的每周血液学大回合中的其他中心,
每年两次进行中心务虚会,以促进临床,基本,基础之间的多学科合作
并翻译了血液学研究人员; (2)与
培养早期研究者的目的是作为非恶性血液学研究学者的目标; (3)到
在我们的博士后研究员中心内维持和丰富教育资源和研究生
学生; (4)支持本科和高中生的夏季培训计划
旋转专注于非恶性血液学研究的实验室,目的是促进
意识和增强年轻人的热情有望在非麻烦中进行研究
血液学领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Russell E Ware其他文献
A Population Pharmacokinetic Analysis of l-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects
镰状细胞病患者 L-谷氨酰胺暴露的群体药代动力学分析:剂量和食物影响的评估
- DOI:
10.1007/s40262-024-01349-4 - 发表时间:
2024 - 期刊:
- 影响因子:4.5
- 作者:
Alina Sadaf;M. Dong;A. Pfeiffer;Teresa S. Latham;T. Kalfa;A. Vinks;Russell E Ware;Charles T Quinn - 通讯作者:
Charles T Quinn
The bold promise of gene therapy for sickle cell disease
镰状细胞病基因疗法的大胆前景
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:6.5
- 作者:
Russell E Ware;Charles T Quinn - 通讯作者:
Charles T Quinn
Russell E Ware的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Russell E Ware', 18)}}的其他基金
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
利用羟基脲 (REACH) 在各大洲实现有效性:羟基脲治疗镰状细胞性贫血儿童的 I/II 期初步研究
- 批准号:
10001581 - 财政年份:2017
- 资助金额:
$ 12.56万 - 项目类别:
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
利用羟基脲 (REACH) 在各大洲实现有效性:羟基脲治疗镰状细胞性贫血儿童的 I/II 期初步研究
- 批准号:
9764461 - 财政年份:2017
- 资助金额:
$ 12.56万 - 项目类别:
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
利用羟基脲 (REACH) 在各大洲实现有效性:羟基脲治疗镰状细胞性贫血儿童的 I/II 期初步研究
- 批准号:
10223406 - 财政年份:2017
- 资助金额:
$ 12.56万 - 项目类别:
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
利用羟基脲 (REACH) 在各大洲实现有效性:羟基脲治疗镰状细胞性贫血儿童的 I/II 期初步研究
- 批准号:
10444370 - 财政年份:2017
- 资助金额:
$ 12.56万 - 项目类别:
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
利用羟基脲 (REACH) 在各大洲实现有效性:羟基脲治疗镰状细胞性贫血儿童的 I/II 期初步研究
- 批准号:
10679001 - 财政年份:2017
- 资助金额:
$ 12.56万 - 项目类别:
相似国自然基金
磁性功能微球在核酸快速提取及检测中的基础科学问题探究
- 批准号:52373131
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
极端高温环境流动沸腾技术的基础科学问题及关键材料研究
- 批准号:52333015
- 批准年份:2023
- 资助金额:230 万元
- 项目类别:重点项目
先进航空发动机中超临界态煤油燃烧过程中的基础科学问题研究
- 批准号:52336006
- 批准年份:2023
- 资助金额:230 万元
- 项目类别:重点项目
企业基础科学研究的动因、机制与经济效果研究
- 批准号:72302229
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
耐高温高电压SiC功率器件灌封材料的多性能协同中的基础科学问题研究
- 批准号:52272001
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
The Meharry Cancer Summer Research Program (SuRP)
梅哈里癌症夏季研究计划 (SuRP)
- 批准号:
10715291 - 财政年份:2023
- 资助金额:
$ 12.56万 - 项目类别:
2023 Muscle: Excitation-Contraction Coupling Gordon Research Conference and Gordon Research Seminar
2023肌肉:兴奋-收缩耦合戈登研究会议暨戈登研究研讨会
- 批准号:
10606049 - 财政年份:2023
- 资助金额:
$ 12.56万 - 项目类别:
2021 Mitochondria in Health and Disease Gordon Research Conference
2021 年线粒体健康与疾病戈登研究会议
- 批准号:
10236763 - 财政年份:2023
- 资助金额:
$ 12.56万 - 项目类别:
56th Annual Meeting of the Society for Leukocyte Biology
白细胞生物学学会第 56 届年会
- 批准号:
10752090 - 财政年份:2023
- 资助金额:
$ 12.56万 - 项目类别:
Cancer Research Training and Education Coordination
癌症研究培训和教育协调
- 批准号:
10625752 - 财政年份:2023
- 资助金额:
$ 12.56万 - 项目类别: